← Back
$DYN All transactions

Dyne Therapeutics, Inc.

A

$ Value

$0

Shares

35,000

Price

$0

Filed

Jun 3

Insider

Name

Stehman-Breen Catherine

Title

CIK

0001702233

Roles

Director

Transaction Details

Transaction Date

2025-05-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

35,000

Footnotes

This option was granted on May 30, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 30, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service.

Filing Info

Accession No.

0000950170-25-081353

Form Type

4

Issuer CIK

0001818794

Stehman-Breen Catherine's History

Date Ticker Type Value
2025-06-04 GBIO A $0
2025-05-30 DYN A $0
2025-05-29 TNYA A $0

Other Insiders at DYN (90d)

Insider Bought Sold Last
Posner Brian S $34K 2026-03-30
Rhodes Jason P $16.5M 2026-04-22
Lucera Erick
Chief Financial Officer
$107K 2026-04-01
Kersten Dirk $9.1M 2026-04-22